Belite BIO Inc
BLTENASDAQStock · Data from SEC EDGAR 13F · Held by 5 of 87 tracked investors
Belite BIO Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation14
- Growth–
- Profitability25
- Quality15
- Debt100
- Stability33
- ✓It has more cash than debt.
- ✓The analysts' average target is 57% above the price.
- !The company is loss-making: net profit is negative.
- !The stock is expensive: you pay 64.5 USD for 1 USD of annual earnings.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveThe company has no earnings, so the P/E cannot be calculated.
- P/E
- –
- P/S
- –
- EV/EBITDA
- –
Is the company growing?
–Too few years to compare. Last year –.
Does it make money?
Loss-makingNet margin: 0.0%.
Is it financially healthy?
Yes- Cash
Earnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 12 Aug 2026 | -0.70 | -0.73 | +4.1% |
| Mar 2026 | 20 May 2026 | -0.34 | -0.60 | +43.3% |
| Dec 2025 | 2 Mar 2026 | -0.38 | -0.56 | +32.1% |
| Sep 2025 | 10 Nov 2025 | -0.65 | -0.53 | -22.6% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart BLTE
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
5LA Lee Ainslie Maverick Capital | 0.54% |
SD Stanley Druckenmiller Duquesne Family Office | 0.31% |
IE Israel Englander Millennium Management | 0.03% |
JS Jim Simons Renaissance Technologies | 0.01% |
SC Steven Cohen Point72 Asset Management | 0.01% |
Frequently asked questions
How much is Belite BIO Inc (BLTE) stock?
Belite BIO Inc shares trade at $145.72, +1.65% over the last trading day. The price is delayed.
What is the market cap of Belite BIO Inc?
The market cap of Belite BIO Inc is about $5.9B.
Which big investors hold Belite BIO Inc?
According to the latest 13F filings, 5 of 87 tracked investors hold Belite BIO Inc, for example Lee Ainslie, Stanley Druckenmiller, Israel Englander.
When will Belite BIO Inc report its next results?
The next earnings report of Belite BIO Inc is expected on 9 Nov 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.